DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $49,942,111 | -1.0% | 201,298 | -4.2% | 0.58% | +9.5% |
| Q2 2023 | $50,426,933 | +66507.1% | 210,113 | -30.1% | 0.53% | -35.3% |
| Q1 2023 | $75,708 | -12.1% | 300,384 | -7.4% | 0.82% | -15.1% |
| Q4 2022 | $86,100 | -99.9% | 324,392 | -2.3% | 0.96% | -6.0% |
| Q3 2022 | $85,765,000 | +3.2% | 332,057 | +1.3% | 1.02% | +9.2% |
| Q2 2022 | $83,138,000 | -15.7% | 327,911 | -2.5% | 0.94% | -0.8% |
| Q1 2022 | $98,644,000 | -9.3% | 336,318 | +1.7% | 0.94% | -6.1% |
| Q4 2021 | $108,804,000 | -49.0% | 330,578 | -52.8% | 1.00% | -2.0% |
| Q3 2021 | $213,390,000 | +124.9% | 700,936 | +98.3% | 1.03% | +11.5% |
| Q2 2021 | $94,868,000 | +15.0% | 353,460 | -3.4% | 0.92% | +12.9% |
| Q1 2021 | $82,462,000 | +1.3% | 365,976 | -0.2% | 0.82% | -10.0% |
| Q4 2020 | $81,410,000 | +1.6% | 366,569 | -1.4% | 0.91% | -16.7% |
| Q3 2020 | $80,109,000 | +25.1% | 371,875 | +2.7% | 1.09% | +1.1% |
| Q2 2020 | $64,034,000 | +30.0% | 362,140 | +1.8% | 1.08% | +7.5% |
| Q1 2020 | $49,266,000 | -10.4% | 355,633 | -0.8% | 1.00% | +17.4% |
| Q4 2019 | $55,012,000 | +6.1% | 358,545 | -0.2% | 0.85% | +6.0% |
| Q3 2019 | $51,863,000 | -5.1% | 359,201 | -6.0% | 0.80% | -2.5% |
| Q2 2019 | $54,644,000 | +7.8% | 382,285 | -0.4% | 0.83% | +5.0% |
| Q1 2019 | $50,674,000 | +27.3% | 383,915 | -0.5% | 0.79% | +14.7% |
| Q4 2018 | $39,807,000 | -2.5% | 386,029 | +2.7% | 0.69% | +14.1% |
| Q3 2018 | $40,839,000 | +9.2% | 375,843 | -0.9% | 0.60% | +5.4% |
| Q2 2018 | $37,407,000 | +15.6% | 379,071 | +14.7% | 0.57% | -23.9% |
| Q1 2018 | $32,347,000 | +3.6% | 330,373 | -1.8% | 0.75% | +9.0% |
| Q4 2017 | $31,221,000 | +6.7% | 336,357 | -1.4% | 0.69% | +1.2% |
| Q3 2017 | $29,254,000 | +10.9% | 341,041 | +9.1% | 0.68% | +9.3% |
| Q2 2017 | $26,370,000 | -1.4% | 312,478 | -0.1% | 0.62% | -3.9% |
| Q1 2017 | $26,749,000 | +12.0% | 312,739 | +1.9% | 0.65% | +7.7% |
| Q4 2016 | $23,886,000 | +6.3% | 306,857 | +7.1% | 0.60% | +4.2% |
| Q3 2016 | $22,461,000 | -21.7% | 286,529 | +0.8% | 0.58% | -23.8% |
| Q2 2016 | $28,701,000 | +5.6% | 284,171 | -0.8% | 0.76% | +12.3% |
| Q1 2016 | $27,184,000 | +4.2% | 286,574 | +2.0% | 0.67% | +7.3% |
| Q4 2015 | $26,089,000 | +6.9% | 280,889 | -2.0% | 0.63% | +5.4% |
| Q3 2015 | $24,413,000 | -1.2% | 286,502 | -0.8% | 0.60% | +7.6% |
| Q2 2015 | $24,711,000 | -1.3% | 288,709 | -2.1% | 0.55% | -1.8% |
| Q1 2015 | $25,043,000 | -5.0% | 294,966 | -4.1% | 0.56% | -5.4% |
| Q4 2014 | $26,370,000 | +2.3% | 307,671 | -9.3% | 0.60% | -0.2% |
| Q3 2014 | $25,787,000 | -3.7% | 339,389 | -0.2% | 0.60% | -6.6% |
| Q2 2014 | $26,782,000 | -47.6% | 340,175 | -50.1% | 0.64% | +4.4% |
| Q1 2014 | $51,124,000 | -9.5% | 681,660 | -6.9% | 0.61% | -7.8% |
| Q4 2013 | $56,496,000 | +118.3% | 731,808 | +96.0% | 0.66% | +3.8% |
| Q3 2013 | $25,881,000 | +13.2% | 373,354 | +3.4% | 0.64% | +6.0% |
| Q2 2013 | $22,855,000 | +13.5% | 361,065 | +11.4% | 0.60% | +12.7% |
| Q1 2013 | $20,140,000 | – | 324,058 | – | 0.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |